Which has grown faster, CDXS or KRSA?

Over the past five years, CDXS grew revenue faster — CDXS at a 0.38% CAGR versus KRSA at -11.98%.

How have CDXS and KRSA total returns compared?

Over the past 5 years, CDXS delivered -44.64% and KRSA delivered -40.41% annualized total return. Past performance doesn't predict future results.

Codexis, Inc. (CDXS) vs Korsana Biosciences, Inc. (KRSA)

A side-by-side comparison of Codexis, Inc. and Korsana Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CDXS

Codexis, Inc.

$153M

$1.42HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

KRSA

Korsana Biosciences, Inc.

$147M

$31.31HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT

Total return — CDXS vs KRSA

growth of $100 · dividends reinvested · last 8y

CDXS -93.3% (-28.7%/yr)KRSA -98.2% (-39.7%/yr)CDXS compounded faster over this window

CDXS KRSA

CDXS vs KRSA: by the numbers

•CDXS is the larger company ($153M vs $147M market cap).
•Both run net losses; CDXS's is the smaller (-39.55% vs -353.00% net margin).
•CDXS grew revenue faster over the past five years (0.38% vs -11.98% CAGR).

Metrics side by side

Valuation

Metric	CDXS	KRSA
P/S ratio	1.97	77.15
P/B ratio	4.63	28.82

Profitability

Metric	CDXS	KRSA
Gross margin	83.71%	100.00%
Operating margin	-54.46%	-239.78%
Net margin	-39.55%	-353.00%
ROE	-93.22%	-131.85%
ROIC	-23.41%	-134.15%

Growth (annualized)

Metric	CDXS	KRSA
Revenue CAGR (5Y)	0.38%	-11.98%
Total return CAGR (5Y)	-44.64%	-40.41%

Frequently asked

Which has grown faster, CDXS or KRSA?: Over the past five years, CDXS grew revenue faster — CDXS at a 0.38% CAGR versus KRSA at -11.98%.
How have CDXS and KRSA total returns compared?: Over the past 5 years, CDXS delivered -44.64% and KRSA delivered -40.41% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CDXS analysis Full KRSA analysis Interactive comparison tool

Dig into the metrics

Codexis ROE Korsana Biosciences ROE Codexis operating margin Korsana Biosciences operating margin Codexis revenue growth Korsana Biosciences revenue growth Codexis free cash flow Korsana Biosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.